News

In 2023, an emergency colonoscopy led to Michael's diagnosis of stage 3 cancer. Because of his experience, Michael Kathrens, 70, advocates for proactive health screenings and being an advocate for your own health.

This week, Marc Roth, MD, medical director of gastrointestinal oncology at Saint Luke’s Cancer Institute and interim chief of medical oncology, is breaking down these latest advancements and what they mean for patients.

Weeks shy of the bar exam, the trajectory of Jackson’s life was rocked off course when he was diagnosed with stage 3 colon cancer. The 26-year-old’s diagnosis was an obstacle that he refused to let topple him.

While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some patients to forgo these often harsh and invasive methods altogether.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

Heart disease remains the number one health threat for women, causing 1 in 3 deaths each year—that's more than all forms of cancer combined.

Grace Webb, Nutritional Coordinator with Saint Luke's Food As Medicine Everyday (FAME) program, shares a warm and nutritious recipe perfect for cold days with KC Live.

Dr. Tracy Stevens, MD, medical director of Saint Luke’s Muriel I. Kauffman Women’s Heart Center, joined KCTV live from Hy-Vee this National Wear Red Day to discuss the risks women face when it comes to cardiovascular disease.

Health Central sat down with cardiologist Tracy Stevens, MD, the medical director of Saint Luke's Muriel I. Kauffman Women’s Heart Center, to discuss warning signs of hypertension and when it's time to see a doctor.

The new Saint Luke’s Muriel I. Kauffman Institute for Women’s Cardiovascular Research is the first of its kind dedicated to studying unique aspects of heart conditions in women.